Confirmation of FAM159B’s predicted size and antibody specificity was achieved in BON-1 cells, a neuroendocrine tumour cell line endogenously expressing FAM159B, using targeted siRNA. The gene discussed is SHISAL2B; the disease is neuroendocrine neoplasm.